Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
株式のランク #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
株価
$0.00695
最終同期: 2024-10-29
時価総額
$536.40
変化(1日)
-0.71%
変化(1年)
0.00%
US
取引 BIOLASE, Inc. (BIOL)

カテゴリー

BIOLASE, Inc.(BIOL)の収益
Sep 2024 時点の収益 TTM: $46.03M
BIOLASE, Inc. の最新の財務報告によると、現在の収益 (TTM) は $46.03M です。2022 年には $48.46M の収益があり、これは 2021 年の $39.19M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
BIOLASE, Inc. の収益履歴(2000 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $46.03M -6.38%
2023 $49.16M 1.45%
2022 $48.46M 23.67%
2021 $39.19M 72.03%
2020 $22.78M -39.73%
2019 $37.80M -18.10%
2018 $46.16M -1.64%
2017 $46.93M -9.43%
2016 $51.81M 6.88%
2015 $48.48M 1.72%
2014 $47.66M -15.55%
2013 $56.43M -1.61%
2012 $57.36M 17.39%
2011 $48.86M 86.30%
2010 $26.23M -39.50%
2009 $43.35M -32.93%
2008 $64.63M -3.38%
2007 $66.89M -4.03%
2006 $69.70M 12.46%
2005 $61.98M 2.19%
2004 $60.65M 23.57%
2003 $49.08M 68.09%
2002 $29.20M 63.24%
2001 $17.89M 85.22%
2000 $9.66M 0.00%
同業他社の収益
企業 収益 収益の差
$46.59B 101,114.53%
US
$25.84B 56,035.66%
US
$35.48B 76,995.55%
IE
$21.00B 45,517.69%
US
$6.51B 14,049.18%
US